Search results for "Vaccinations"
Latest COVID-19 research details local vaccine reactions, ineffective outpatient treatments
A case series described delayed skin reactions to vaccination, and randomized trials indicated that ivermectin, azithromycin, and convalescent plasma didn't help mildly ill patients. Several studies focused on the increase in alcohol use during the pandemic.
https://immattersacp.org/weekly/archives/2021/03/09/1.htm
9 Mar 2021
Regulatory changes for COVID-19 vaccine; data on waning immunity, outpatient therapies
The FDA authorized vaccinating children, the NIH supported concurrent use of flu and COVID-19 shots, and the CDC addressed a fourth dose of COVID-19 vaccine for the immunocompromised. Trials found benefit from a new monoclonal antibody and an old antidepressant for high-risk outpatients.
https://immattersacp.org/weekly/archives/2021/11/02/1.htm
2 Nov 2021
Immunization is everyone's issue
ACP convened an Advisory Group to discuss barriers to adult immunization, with the goal of identifying potential ways for ACP to address them on a population health level.
https://immattersacp.org/archives/2019/10/immunization-is-everyones-issue.htm
1 Oct 2019
Distribution plans, data on vaccines; NIH cautious on latest antibody treatment
The Advisory Committee on Immunization Practices chose clinicians and long-term care residents for priority vaccination, while ACP offered additional input on the topic. The NIH said that casirivimab plus imdevimab should not be standard of care, and the CDC offered recommendations on shortening quarantine.
https://immattersacp.org/weekly/archives/2020/12/08/1.htm
8 Dec 2020
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021
Latest COVID-19 research looks at vaccines' efficacy, thrombocytopenia risk
Thrombosis with thrombocytopenia is a risk with the Johnson & Johnson (Janssen) vaccine, but not those using mRNA technology, one study found, while other research quantified the vaccines' effectiveness over time. A trial found that monoclonal antibodies reduced progression from asymptomatic to symptomatic infection.
https://immattersacp.org/weekly/archives/2022/01/18/1.htm
18 Jan 2022
Raising vaccine rates requires some selling
Physicians and others in their practice can boost their odds of vaccination success by the way they frame conversations with patients.
https://immattersacp.org/archives/2020/06/raising-vaccine-rates-requires-some-selling.htm
1 Jun 2020
New adult immunization video series now available from ACP
The series, featuring Sandra Adamson Fryhofer, MD, MACP, provides a comprehensive review of the 2021 Advisory Committee on Immunization Practices' adult immunization recommendations, including new information on COVID-19 vaccines.
https://immattersacp.org/weekly/archives/2021/04/06/4.htm
6 Apr 2021
New research on mixed vaccine boosters, long-term outcomes, omicron severity
A study found mixing and matching of COVID-19 vaccines to be safe and effective, other research showed ongoing symptoms to be common at one year after infection, the CDC analyzed the severity of omicron, and the FDA revised outpatient treatment authorizations.
https://immattersacp.org/weekly/archives/2022/02/01/1.htm
1 Feb 2022
ACP offers free webinars on immunization on Aug. 23, Sept. 12, Sept. 23
Upcoming webinars for National Immunization Awareness Month will cover resident education, immunization in HIV, and development of a vaccination program.
https://immattersacp.org/weekly/archives/2019/08/20/5.htm
20 Aug 2019